-+ 0.00%
-+ 0.00%
-+ 0.00%
NovaBridge Biosciences Chief Commercial Officer Mark Arnold Hagler Reports $85,864 Common Share Acquisition
Share
Listen to the news
NovaBridge Biosciences Chief Commercial Officer Mark Arnold Hagler Reports $85,864 Common Share Acquisition
  • NovaBridge Biosciences Chief Commercial Officer Mark Arnold Hagler purchased 230,000 ordinary shares.
  • The purchases comprised 46,000 ordinary shares at $0.343 each and 184,000 at $0.381 each.
  • His direct beneficial ownership rose to 460,000 ordinary shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002126029-26-000006), on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending